A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Carcinoma, Non-Small-Cell Lung Bronchial Neoplasms Carcinoma, Bronchogenic Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

RTI Health Solutions

Research Triangle Park, North Carolina, 27709, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The following is the inclusion criteria for pretest interviews and final online survey.

Participants:

Must be 18 years of age or older
Must be a US resident.
Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.

Exclusion criteria

Not applicable

Other protocol-defined inclusion/exclusion criteria apply

Treatment and study plan

Primary outcomes

Set of relative preference weights for all attribute levels included in the Discrete Choice Experiment (DCE)

Time frame: At Baseline
Respondents' baseline understanding of attribute descriptions

Time frame: At Baseline

Sponsors and collaborators

Lead sponsor

Bristol-Myers Squibb

Industry

Registry information

Official study title

Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Important dates

Study start: 2021
Primary completion: 2023
Study completion: 2023
First posted: Feb 22, 2022
Registry last updated: Jun 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed